Pulmatrix, Inc. Gains 39.57%
Fri, Nov 15, 2024 at 07:22 PM
Pulmatrix, Inc. (PULM:NASDAQ) soared at $6.56, a gain of 39.6%. On Fri, Nov 15, 2024, PULM:NASDAQ touched a New 2-Week High of $6.56. The stock appeared on our News Catalysts scanner on Wed, Nov 13, 2024 at 11:21 AM in the 'MERGER' category. From Fri, Nov 01, 2024, the stock recorded 50.00% Up Days and 36.36% Green Days
The stock spiked on Thu, Nov 14, 2024 at $7.87 with a volume of 14M+.
About Pulmatrix, Inc. (PULM:NASDAQ)
Pulmatrix Inc is is a clinical stage biotechnology company. The Company is engaged in discovery and development of a novel class of inhaled therapeutic products intended to prevent and treat respiratory diseases and infections.
Top 10 Gainers:
- The Arena Group Holdings Inc. (AREN:NYSEMKT), 207.02%
- Bloom Energy Corporation (BE:NYSE), 59.19%
- CERo Therapeutics Holdings Inc Com (CERO:NASDAQ), 52.4%
- Cyclerion Therapeutics, Inc. (CYCN:NASDAQ), 45.76%
- SIMPPLE LTD. (SPPL:NASDAQ), 43.47%
- Pulmatrix, Inc. (PULM:NASDAQ), 39.57%
- Trilogy Metals Inc. (TMQ:NYSEMKT), 36.66%
- Zentek Ltd. (ZTEK:NASDAQ), 30.64%
- Solidion Technology Inc. (STI:NASDAQ), 28.63%
- Fitell Corporation (FTEL:NASDAQ), 28.55%